| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OPTIMA MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,080 | -2,06 % | Aurora Cannabis: Deal-Hürde fällt - was jetzt noch fehlt | ||
| CANOPY GROWTH | 0,488 | -1,99 % | Ihre wichtigsten Termine: Spannende Updates von: Moderna, Krones, Daimler Truck, Under Armour & Brookfield | © Foto: Bodo Schackow/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: CA29250N1050... ► Artikel lesen | |
| TILRAY BRANDS | 2,125 | -0,70 % | Tilray Brands in downtrend: Bearish signals defy Wall Street's 'Buy' call | ||
| ABBOTT LABORATORIES | 95,02 | -2,80 % | Dividendenbekanntmachungen (16.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD EUR ABBVIE INC US00287Y1091 1,73 USD EUR AGCO CORPORATION US0010841023 0,3 USD 0... ► Artikel lesen | |
| SINOPHARM | 1,937 | +0,94 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| AMARIN | 10,200 | -0,97 % | Amarin Corporation plc: Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence | Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA's... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 17,155 | +0,94 % | Acadia presents additional data on Alzheimer's psychosis drug | ||
| BRIDGEBIO PHARMA | 69,50 | -1,11 % | BridgeBio Pharma, Inc.: Acoramidis Was Associated with Lower Risk of Worsening Heart Failure Versus Tafamidis in Real-World Study and Reduced Heart Failure Events Within One Month in ATTRibute-CM | ||
| CNBX PHARMACEUTICALS | - | - | CNBX Pharmaceuticals bestellt neuen Abschlussprüfer | ||
| ARGENT BIOPHARMA | 0,011 | 0,00 % | ARGENT BIOPHARMA LIMITED: Becoming a substantial holder | ||
| CENTR BRANDS | 0,009 | 0,00 % | Centr Brands Corp (2): Centr Brands extends maturity dates of debentures | ||
| LABORATORIOS FARMACEUTICOS ROVI | 68,70 | -0,87 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.2026 | Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen.
1. US88025U1097 10X GENOMICS INC
2. NL0000852564 AALBERTS NV
3. SE0016589188 ELECTROLUX AB
4. SE0000115446... ► Artikel lesen | |
| AVECHO BIOTECHNOLOGY | 0,007 | -100,00 % | AVECHO BIOTECHNOLOGY LIMITED: Avecho presents at BIO-Europe | ||
| HERON THERAPEUTICS | 0,250 | -2,87 % | CRMD to Acquire HRTX Assets for $223M Upfront to Expand Portfolio |